22 unknown. 22 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Unknown 22 |
| Phase 2 | 1 | Unknown 1 |
Follow Hepatitis B: new trials by email Literature Review of Hepatitis B trials Research Report on Hepatitis B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study Pradefovir Mesylate;Placebo of Tenofovir disoproxil fumarate tablet, Tenofovir disoproxil fumarate tablet;Placebo of Pradefovir Mesylate - Chronic Hepatitis b | Phase 3 | Unknown | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 900 | 2020-09-01 | 2020-09-10 |
| Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity Ribavirin, Tenofovir - Hepatitis B, Chronic | Phase 3 | Unknown | Ottawa Hospital Research Institute | 24 | 2019-01-10 | 2021-09-14 |
| Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation 4th dose of hexavalent vaccine 1 month after the 3rd dose - Haemopoietic Stem Cell Transplantation, Allograft | Phase 3 | Unknown | University Hospital, Grenoble | 200 | 2018-05-01 | 2018-06-06 |
| HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 GC1102 80,000 IU, GC1102 100,000 IU, I.V HBIG - Hepatitis B Infection | Phase 2 / Phase 3 | Unknown | Green Cross Corporation | 186 | 2018-03-29 | 2020-01-30 |
| HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg Commercial Hepatitis B vaccine, Standard Treatment - Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine | Phase 3 | Unknown | Mahidol University | 97 | 2017-03-30 | 2018-01-23 |
| Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers Ibrutinib - Chronic Lymphocytic Leukemia, Indolent B-cell Lymphomas | Phase 3 | Unknown | The University of Hong Kong | 62 | 2016-11-01 | 2018-04-12 |
| Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet CKD-390, viread - Chronic Hepatitis B | Phase 3 | Unknown | Chong Kun Dang Pharmaceutical | 158 | 2016-04-01 | 2016-06-21 |
| Tenofovir to Prevent HBV Reactivation Tenofovir disoproxil, Placebo Oral Tablet - Hepatitis B, Lymphoma | Phase 3 | Unknown | University Health Network, Toronto | 184 | 2015-05-01 | 2019-12-12 |
| A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) Y peginterferon alfa-2b, Granulocyte-macrophage colony stimulating factor, Entecavir and or adefovir dipivoxil - Hepatitis B, Chronic | Phase 3 | Unknown | Tongji Hospital | 300 | 2014-10-01 | 2016-08-15 |
| Phase 3 and Extensional Study of Besifovir besifovir 150mg, tenofovir 300mg - Chronic Hepatitis B | Phase 3 | Unknown | IlDong Pharmaceutical Co Ltd | 197 | 2013-10-01 | 2020-01-27 |
| Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B PEG-Tα1, Placebo to match PEG-Tα1, Adefovir - Hepatitis B, Chronic | Phase 3 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 463 | 2013-08-01 | 2015-02-19 |
| HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance PEG-interferon-Alfa-2A, Nucleosides - Chronic Hepatitis B | Phase 3 | Unknown | Pusan National University Hospital | 144 | 2013-05-01 | 2014-11-04 |
| Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation Tenofovir, lamivudine - Chronic HBV With Severe Exacerbation | Phase 3 | Unknown | Kaohsiung Veterans General Hospital. | 120 | 2013-04-01 | 2014-09-16 |
| Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients Sci-B-Vac Hepatitis B Vaccine, Engerix B Hepatitis B Vaccine - Chronic Kidney Disease, Hepatitis B | Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 100 | 2012-03-01 | 2013-09-02 |
| NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients NASVAC, Pegylated interferon alpha 2b - Chronic Hepatitis B | Phase 3 | Unknown | Clinical Research Organization, Dhaka, Bangladesh | 160 | 2011-06-01 | 2012-12-12 |
| A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B Pegylated interferon-alpha-2a, Nucleotidic or Nucleosidic Treatment - Chronic Hepatitis B, AgHbs Negativation | Phase 3 | Unknown | ANRS, Emerging Infectious Diseases | 185 | 2011-01-01 | 2013-03-29 |
| Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects Hepavax-Gene - HIV Infection | Phase 3 | Unknown | Chiang Mai University | 132 | 2011-01-01 | 2011-02-03 |
| Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B telbivudine - Chronic Hepatitis B | Phase 3 | Unknown | Yonsei University | 110 | 2010-06-01 | 2012-02-02 |
| Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. Entecavir and Pegylated interferon α-2a Sequential Treatment Group, Pegylated interferon α-2a Monotreatment Group - Hepatitis B, Chronic | Phase 3 | Unknown | Hanyang University | 228 | 2010-06-01 | 2011-07-04 |
| Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B medical ozone therapy with tianyi, medical ozone therapy with humares, Diammonium glycyrrhizinate Capsules - Chronic Hepatitis B | Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 189 | 2010-03-01 | 2012-10-18 |
Showing 20 of 22. Sign in to see all of them.
Hepatitis B, Chronic (15) · HIV Infections (2) · Hepatitis A (1) · Hepatitis C, Chronic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Poliomyelitis (1) · Renal Insufficiency, Chronic (1) · Tetanus (1) · Waldenstrom Macroglobulinemia (1)
Blood-Borne Infections (22) · Communicable Diseases (22) · DNA Virus Infections (22) · Digestive System Diseases (22) · Hepadnaviridae Infections (22) · Hepatitis (22) · Hepatitis, Viral, Human (22) · Infections (22) · Liver Diseases (22) · Virus Diseases (22) · Chronic Disease (16) · Disease Attributes (16) · Pathologic Processes (16) · Pathological Conditions, Signs and Symptoms (16) · Hepatitis, Chronic (15)
Tenofovir (5) · peginterferon alfa-2a (4) · Ribavirin (2) · entecavir (2) · peginterferon alfa-2b (2) · ((1-((2-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxyl (1) · Colony-Stimulating Factors (1) · Drugs, Generic (1) · Engerix-B (1) · Glycyrrhizic Acid (1) · Interleukin-2 (1) · Lamivudine (1) · Nucleosides (1) · Telbivudine (1) · adefovir (1)
ANRS, Emerging Infectious Diseases (1) · Aalborg University Hospital (1) · Chiang Mai University (1) · Chong Kun Dang Pharmaceutical (1) · Clinical Research Organization, Dhaka, Bangladesh (1) · Green Cross Corporation (1) · Hanyang University (1) · IlDong Pharmaceutical Co Ltd (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Kaohsiung Veterans General Hospital. (1) · Mahidol University (1) · Nanfang Hospital, Southern Medical University (1) · National Taiwan University Hospital (1) · Ottawa Hospital Research Institute (1) · Pusan National University Hospital (1)
South Korea (6) · China (4) · Canada (2) · France (2) · Taiwan (2) · Thailand (2) · Bangladesh (1) · Denmark (1) · Hong Kong (1) · Israel (1)
Byung Seok Lee, M.D., Ph.D. (1) · Curtis L Cooper, MD (1) · Dong Joon Kim, M.D., Ph.D. (1) · Henrik Nielsen, MD, DMSci (1) · Hong Soo Kim, M.D., Ph.D. (1) · Hyung Joon Yim, M.D., Ph.D. (1) · Jae-Youn Cheong, M.D., Ph.D. (1) · Jeong Heo, Dr (1) · Jin-Woo Lee, M.D., Ph.D. (1) · JinMo Yang, M.D., Ph.D. (1) · Joo Hyun Sohn, M.D., Ph.D. (1) · Joo Hyun Sohn, MD, Ph.D (1) · Junqi Niu, Dr. (1)
PMID 24265819, PMID 24431895, PMID 28404133, PMID 29682590, PMID 29998882, PMID 30133478, PMID 30448598, PMID 31711528, PMID 32355123, PMID 33493393, PMID 34807763, PMID 35149125, PMID 35867702, PMID 36586101, PMID 38473248, PMID 40665748, PMID 41144397, PMID 41335575, PMID 41366186